drugset / Trial / NCT01405261
Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects
RandomizedSingle-groupDouble-blindTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to investigate safety, tolerability and pharmacokinetics (the exposure of the trial drug in the body) of single doses of NNC 0113-0987 in healthy male subjects.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NNC0113-0987 | Unknown | — | Oral |